MRNTY - Medicrea International SA

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • Business Wire

    MEDICREA Is Protected From the Consequences of the COVID-19 Pandemic

    The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, communicates on the consequences on its activity of the COVID-19 pandemic and the measures it has taken to deal with it.

  • Is Medicrea International SA's (EPA:ALMED) CEO Salary Justified?
    Simply Wall St.

    Is Medicrea International SA's (EPA:ALMED) CEO Salary Justified?

    The CEO of Medicrea International SA (EPA:ALMED) is Denys Sournac. First, this article will compare CEO compensation...